embecta

At embecta (formerly part of BD) we are a global medical technology company singularly focused on improving the lives of people living with diabetes. For nearly 100 years, we’ve been developing and providing solutions to the diabetes community. We are the leaders in insulin delivery, with more than 30 million people in over 100 countries relying on our pen needle and syringe products.

See below for the Latest embecta News, Analysis, Profit Results, Share Price Information, and Commentary.